Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.47 |
| ▸ | FABP7 | O15540 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24633715 | 1.00 | FABP5 (0.47) | FABP5FABP7PPARGPPARAKMT2A | |
| SCHEMBL25178524 | 1.00 | FABP5 (0.47) | FABP5FABP7PPARGPPARAKMT2A | |
| SCHEMBL29855186 | 1.00 | FABP5 (0.47) | FABP5FABP7PPARGPPARAKMT2A | |
| SCHEMBL25360126 | 0.93 | FABP5 (0.44) | FABP5FABP7KMT2AALDH1A1HPGD | |
| SCHEMBL25360123 | 0.93 | FABP5 (0.44) | FABP5FABP7KMT2AALDH1A1HPGD | |
| SCHEMBL31369420 | 0.90 | KMT2A (0.48) | FABP5FABP7KMT2ACASP3 | |
| SCHEMBL21837824 | 0.89 | FABP5 (0.45) | FABP5FABP7KMT2AALDH1A1HPGD | |
| SCHEMBL21837826 | 0.89 | FABP5 (0.45) | FABP5FABP7KMT2AALDH1A1HPGD | |
| SCHEMBL25182166 | 0.88 | FABP5 (0.40) | FABP5FABP7PPARGPPARAKMT2A | |
| SCHEMBL24633714 | 0.88 | FABP5 (0.40) | FABP5FABP7PPARGPPARAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | FABP5 424/4885FABP7 508/4885PPARG 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.